Selected research
Industry Growth & Trends
Global AI Medical Imaging Software for Lung Diseases Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Medical Imaging Software for Lung Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Medical Imaging Software for Lung Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Medical Imaging Software for Lung Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Medical Imaging Software for Lung Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Medical Imaging Software for Lung Diseases market include Riverain Technologies, BioMind, Fosun Aitrox, Huiying Medical, United-Imaging, Deepwise, Shukun Technology, VoxelCloud and Infervision Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Medical Imaging Software for Lung Diseases market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Medical Imaging Software for Lung Diseases market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Medical Imaging Software for Lung Diseases market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Medical Imaging Software for Lung Diseases.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Medical Imaging Software for Lung Diseases market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Medical Imaging Software for Lung Diseases Market by Company
Riverain Technologies
BioMind
Fosun Aitrox
Huiying Medical
United-Imaging
Deepwise
Shukun Technology
VoxelCloud
Infervision Medical
Siemens
Yizhun Intelligent
AI Medical Imaging Software for Lung Diseases Segment by Type
Pulmonary Nodules
Pneumonia
Other
AI Medical Imaging Software for Lung Diseases Segment by Application
Hospital
Clinic
AI Medical Imaging Software for Lung Diseases Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Lung Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Lung Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Lung Diseases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Medical Imaging Software for Lung Diseases companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pulmonary Nodules
- Pneumonia
- Other
Applications
- Hospital
- Clinic
Companies covered
- Riverain Technologies
- BioMind
- Fosun Aitrox
- Huiying Medical
- United-Imaging
- Deepwise
- Shukun Technology
- VoxelCloud
- Infervision Medical
- Siemens
- Yizhun Intelligent
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Medical Imaging Software for Lung Diseases Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2021-2032)
- 1.4.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2021-2026)
- 1.4.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2027-2032)
- 1.5 Key Regions AI Medical Imaging Software for Lung Diseases Market Size (2021-2032)
- 1.5.1 North America AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (2021-2032)
2 AI Medical Imaging Software for Lung Diseases Market by Type
- 2.1 Type Introduction
- 2.1.1 Pulmonary Nodules
- 2.1.2 Pneumonia
- 2.1.3 Other
- 2.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Type
- 2.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Medical Imaging Software for Lung Diseases Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Medical Imaging Software for Lung Diseases Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Medical Imaging Software for Lung Diseases Market Size by Regions
- 2.3.1 North America AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Type (2021-2026)
3 AI Medical Imaging Software for Lung Diseases Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Application
- 3.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Medical Imaging Software for Lung Diseases Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Medical Imaging Software for Lung Diseases Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Medical Imaging Software for Lung Diseases Market Size by Regions
- 3.3.1 North America AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Medical Imaging Software for Lung Diseases Industry Trends
- 4.2 AI Medical Imaging Software for Lung Diseases Industry Drivers
- 4.3 AI Medical Imaging Software for Lung Diseases Industry Opportunities and Challenges
- 4.4 AI Medical Imaging Software for Lung Diseases Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Medical Imaging Software for Lung Diseases Revenue (2021-2026)
- 5.2 Global AI Medical Imaging Software for Lung Diseases Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Medical Imaging Software for Lung Diseases Key Company Headquarters & Area Served
- 5.4 Global AI Medical Imaging Software for Lung Diseases Company, Product Type & Application
- 5.5 Global AI Medical Imaging Software for Lung Diseases Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Medical Imaging Software for Lung Diseases Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Medical Imaging Software for Lung Diseases Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Medical Imaging Software for Lung Diseases Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Riverain Technologies
- 6.1.1 Riverain Technologies Company Information
- 6.1.2 Riverain Technologies Business Overview
- 6.1.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.1.5 Riverain Technologies Recent Developments
- 6.2 BioMind
- 6.2.1 BioMind Company Information
- 6.2.2 BioMind Business Overview
- 6.2.3 BioMind AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BioMind AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.2.5 BioMind Recent Developments
- 6.3 Fosun Aitrox
- 6.3.1 Fosun Aitrox Company Information
- 6.3.2 Fosun Aitrox Business Overview
- 6.3.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.3.5 Fosun Aitrox Recent Developments
- 6.4 Huiying Medical
- 6.4.1 Huiying Medical Company Information
- 6.4.2 Huiying Medical Business Overview
- 6.4.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.4.5 Huiying Medical Recent Developments
- 6.5 United-Imaging
- 6.5.1 United-Imaging Company Information
- 6.5.2 United-Imaging Business Overview
- 6.5.3 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 United-Imaging AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.5.5 United-Imaging Recent Developments
- 6.6 Deepwise
- 6.6.1 Deepwise Company Information
- 6.6.2 Deepwise Business Overview
- 6.6.3 Deepwise AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Deepwise AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.6.5 Deepwise Recent Developments
- 6.7 Shukun Technology
- 6.7.1 Shukun Technology Company Information
- 6.7.2 Shukun Technology Business Overview
- 6.7.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.7.5 Shukun Technology Recent Developments
- 6.8 VoxelCloud
- 6.8.1 VoxelCloud Company Information
- 6.8.2 VoxelCloud Business Overview
- 6.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.8.5 VoxelCloud Recent Developments
- 6.9 Infervision Medical
- 6.9.1 Infervision Medical Company Information
- 6.9.2 Infervision Medical Business Overview
- 6.9.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.9.5 Infervision Medical Recent Developments
- 6.10 Siemens
- 6.10.1 Siemens Company Information
- 6.10.2 Siemens Business Overview
- 6.10.3 Siemens AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Siemens AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.10.5 Siemens Recent Developments
- 6.11 Yizhun Intelligent
- 6.11.1 Yizhun Intelligent Company Information
- 6.11.2 Yizhun Intelligent Business Overview
- 6.11.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Portfolio
- 6.11.5 Yizhun Intelligent Recent Developments
7 North America
- 7.1 North America AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2021-2026)
- 7.3 North America AI Medical Imaging Software for Lung Diseases Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2021-2026)
- 8.3 Europe AI Medical Imaging Software for Lung Diseases Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Medical Imaging Software for Lung Diseases Market Size by Country (2021-2026)
- 10.3 South America AI Medical Imaging Software for Lung Diseases Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst